DTx opportunity in the Asian market

 Over 60% of the world's population lives in Asia; this huge population pool (over 4.600M population) combined with the greater use of mobile and digital technologies points to a great opportunity for DTx products in the Asian market. We have steadily seen an increase in demand for digital healthcare in Asia in the last few years that is driven primarily by: (i) a lack of available healthcare infrastructure, (ii) limited reimbursement of healthcare and, (iii) unmet demand for medical professionals. In the region, Japanese companies have been at the forefront of commercializing DTx, with both Otsuka and Shionogi being early leaders in forming pharma partnerships in the sector and pushing forward with building DTx franchises in Japan and other north-Asia countries. In comparison to western markets the penetration of DTx into these markets has been limited, which raises the question of how to best capture the DTx commercial opportunity in the Asian market? Join us in this informal conversation where we will talk about: